Steven Cohen Syndax Pharmaceuticals Inc Call Options Transaction History

Point72 Asset Management, L.P.

  • $44.6 Billion
  • Q2 2025

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2025

May 15, 2025
BUY
$12.29 - $16.38 $843,093 - $1.12 Million
68,600 Added 52.21%
200,000 $2.46 Million
Q4 2024

Feb 14, 2025
BUY
$12.52 - $21.81 $1.65 Million - $2.87 Million
131,400 New
131,400 $1.74 Million
Q2 2024

Aug 14, 2024
BUY
$18.82 - $23.79 $1.18 Million - $1.49 Million
62,500 New
62,500 $1.28 Million

Others Institutions Holding SNDX

# of Institutions
248
Shares Held
100M
Call Options Held
1.28M
Put Options Held
1.29M
View Full List

About Syndax Pharmaceuticals Inc

SNDX Quotes by TradingView
  • Ticker SNDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,565,200
  • Market Cap $916M
  • Description
  • Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...
More about SNDX
Track Steven Cohen's Portfolio

Track Steven Cohen Portfolio

Follow Steven Cohen (Point72 Asset Management, L.P.) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email